Beat cancer? Your Medicare Advantage plan might still be billing for it

Beat cancer? Your Medicare Advantage plan might still be billing for it.

https://www.washingtonpost.com/business/2022/06/05/medicare-advantage-records-fraud/

Firms mined patient records for outdated, irrelevant conditions to increase profits, Justice Department contends

Kathy Ormsby’s work auditing medical case files uncovered an alleged scheme to defraud the federal government: The California health system that employed her was scouring health histories of thousands of elderly Medicare patients, then pressuring doctors to add false diagnoses it found to their current medical records.

The point of larding the medical records with outdated and irrelevant diagnoses such as cancer and stroke — often without the knowledge of the patients themselves — was not providing better care, according to a lawsuit from the Justice Department, which investigated a whistleblower complaint Ormsby filed. It was to make patients appear sicker than they were.

The maneuver translated into millions of dollars in inflated bills to the federal Medicare Advantage insurance program, the government alleged in its false-claims lawsuit filed in U.S. District Court in California.

The case was part of a broader government crackdown on abusive billing practices in Medicare Advantage, the privatized insurance option that by next year is expected to cover more than half of all Medicare beneficiaries. The Justice Department is pursuing civil lawsuits against multiple companies that participate in the privatized system, from huge insurers to prestigious nonprofit hospital systems, alleging they have cheated the system for unfair profit.

Ormsby’s former employer, the Palo Alto Medical Foundation, which has 1,600 doctors, and its parent affiliate, Sutter Health, which runs 24 hospitals in Northern California, settled the case with the government in August 2021 for $90 million. It admitted no wrongdoing or liability.

The government said its investigation confirmed that Palo Alto Medical and Sutter systematically added false diagnoses to patient records. In a sample of hundreds of cases Ormsby audited, the government’s lawsuit said, she discovered 90 percent of diagnoses for cancer were invalid, as were 96 percent for stroke and 66 percent for fractures.

“As we continued to audit, I started to see more things,” Ormsby said in an interview with The Washington Post, the only time she has spoken publicly since reporting the alleged misconduct in 2015. “I couldn’t believe how bad it was.”

In response to questions from The Post, Sutter indicated it was ready to move on. “The agreement brought closure to a long-running dispute and enabled Sutter to avoid the uncertainty and expense of protracted litigation,” it said in an email statement.

Medicare Advantage, which is run by outside companies under contract with the government, was added to traditional Medicare in 2003 with the support of Republicans in an effort to improve care and lower costs through privatization. But it is costing taxpayers increasingly more money to run than traditional fee-for-service Medicare, according to MedPAC, a government watchdog panel. The higher cost, what MedPAC labels “excess payments,” reached $12 billion in 2020 out of total program costs of $350 billion and are projected to top $16 billion next year, MedPAC said in March.

A coronavirus vaccine is administered at a Sutter Health clinic in San Francisco in 2021. (Lea Suzuki/San Francisco Chronicle/Hearst Newspapers via Getty Images)

The aggressive billing tactics stem from incentives built into Medicare Advantage. Under the program, companies are paid a flat fee per month to provide whatever care is required for a patient based on age, gender, geography and health risk factors. To compensate plans and providers for potential costs of care for individual patients with conditions such as diabetes, heart disease or cancer, Medicare boosts the monthly payment to Medicare Advantage plans under a “risk adjustment” for each additional condition. The system differs from the traditional “fee for service” payment, in which Medicare pays hospitals and doctors directly each time they provide a service.

If companies add more risk adjustment codes to a Medicare Advantage beneficiary’s medical record to receive higher payment — but don’t spend money on the additional care — they make more money.

Industry officials broadly rebut the charge that companies game diagnostic risk codes for financial gain. They say Medicare Advantage firms adhere to Medicare’s rules and follow the system’s guidance on regulations that are not always clear. Moreover, the industry says that listing all health issues on medical records is a crucial part of Medicare Advantage’s promise to anticipate health problems, proactively manage disease and reduce hospitalizations.

But the government considers it improper — potentially even fraudulent — for providers to add codes for medical conditions that have been resolved or have no bearing on a patient’s current health.

For-profit insurance companies have typically been the primary target of these probes. More recently, unsealed whistleblower cases such as Ormsby’s against Sutter Health, and a pending case against Kaiser Permanente, reveal how such investigations have spread to prestigious, nonprofit physician and hospital groups.

Doctors, or sometimes even non-physician medical coders, updated patients’ current records without providing treatment and often unbeknown to the patients themselves, the government’s investigations have found.

Heart attack, stroke, cancer, vascular disease, depression, obesity and malnutrition were among diagnoses most often cited by the government in its false-claims lawsuits. In an example cited in the Sutter case, thyroid cancer was added as a current condition in a patient record even after the thyroid gland had been removed five years earlier and the patient had been free of cancer for years. None of the allegations has been fully tested in court, because they were settled by the companies without an admission of liability or, in the case against Kaiser Permanente, remain pending.

Kaiser Permanente is accused in a lawsuit of allegedly bringing in about $1 billion in improper billings from 2009 to 2018. The case is pending. (AaronP/Bauer-Griffin/GC Images)

Some critics contend that a byproduct of these practices is that patients’ medical records, padded with false diagnoses, are inaccurate. That could unnecessarily stigmatize patients who were improperly deemed obese, or malnourished, or mentally ill. It introduces potential phantom influences on treatment decisions, critics say.

In addition to her shock over thousands of alleged false billings, Ormsby “was not comfortable with what she perceived as the complete divorce from the reality of what was in patient records” at Sutter Health, said Sarah “Poppy” Alexander, a whistleblower lawyer at Constantine Cannon, which represented Ormsby.

“The accuracy of patient records is critical for anyone’s health-care treatment,” she said. “Think about all the decisions that are made based on what’s in your health-care record. If that health-care record is not accurate, it’s extremely dangerous.”

Several doctors interviewed by The Washington Post said it was common practice for insurance companies and medical systems to search or data-mine the histories of patients covered by Medicare Advantage. Health systems were known to advise doctors on the most lucrative billing strategies, cajole them to document the maximum number of illnesses, and grade and rank them among their peers based on how they coded patients, they said.

David Terry, a recently retired psychiatrist, said there is pressure to “code for more money.” (Christopher Smith for The Washington Post)

“The emphasis is on how to code for more. It’s not ethical coding, it’s how to code for more money. That pressure is there,” said David Terry, a recently retired psychiatrist who worked within large health organizations in Kansas that are not part of any of the lawsuits.

The Justice Department said in February that Medicare Advantage investigations are an “important priority.” In federal whistleblower cases, the government investigates allegations brought by people with knowledge of alleged fraud against the government and then decides whether it will join the lawsuit, based on its findings. Whistleblowers are rewarded for stepping forward with a portion of any settlement or court awards. Justice Department whistleblower allegations and similar lawsuits also are playing out in federal courts against UnitedHealth Group, Cigna and Anthem. The government’s Office of Inspector General has audited Humana and found it overbilled the government. United Healthcare, which is under the umbrella of UnitedHealth Group, and Kaiser Permanente denied any improper conduct. Cigna, Anthem and Humana did not respond to requests for comment.

The health insurance industry’s trade group, AHIP, did not comment on allegations of false billings. MedPAC’s estimates of excess payments, when compared with traditional Medicare, are exaggerated, AHIP executives said, because its calculations do not factor in all differences between the two payment systems.

“The Medicare Advantage system is designed to promote accurate coding and support integrated care,” said Mark Hamelburg, AHIP senior vice president for federal programs. “Plans

10-year growth in Medicare Advantage Enrollment
2011
2021
Beneficiaries (millions)
11.9
26.9
Share of all Medicare
26%
46%
Source: MedPAC

Medicare Advantage plans cut costs using the tools of the private insurance industry. They control the use of MRIs and other costly tests, for instance, cutting down on waste. They restrict care to certain hospital and physician networks. Then they use a share of those savings to keep monthly premiums lower than traditional Medicare, while offering extra benefits traditional Medicare does not offer, such as dental and hearing and gym memberships.

“It is a vast, complicated system. It involves all these various components,” Hamelburg said. “Our view is that you shouldn’t just look at individual components, you need to look at the totality.”

An industry-backed study found that Medicare Advantage members pay $1,965 less in out-of-pocket costs, including premiums, than traditional Medicare beneficiaries. Beneficiary satisfaction is high. Membership in the plans grew by 10 percent last year; they are expected to cover more than 50 percent of all patients next year.

‘Something unseemly’

Ormsby, one of the Medicare Advantage whistleblowers whose case was investigated by the government, quit her job at Palo Alto Medical Foundation in 2015 after two years in her job as a risk adjustment project manager. An outside consultant had found 8,000 false codes for the years 2012 and 2013, the government alleged in the whistleblower lawsuit she initiated.

The governme investigation of her complaint revealed how physicians received computerized “daily alerts” for their patients flagging “suspected” diagnoses unearthed via data-mining. When their risk-adjustment diagnosis numbers fell short, doctors were urged by higher-ranking colleagues to improve, the government lawsuit alleged. In some cases, the government said, coders would add diagnoses to patient records without participation of doctors.

Some doctors pushed back on the pressure to add diagnostic codes.

“With my patient on hospice, there is something that seems unseemly about pursuing a new diagnosis of PVD [pulmonary vascular disease] when she has weeks to live,” one physician, Joann Falkenburg, wrote to colleagues helping lead the pressure tactics. The email was obtained by Justice Department investigators. “I try to be pretty legitimate about how I diagnose, document and chart and want to avoid any possibility that it looks like I am working someone up just for the financial upside.”

The government’s lawsuit does not indicate how Palo Alto Medical responded to her email, and Falkenburg did not respond to a phone message requesting comment.

A Palo Alto Medical auditor reported in internal correspondence that another physician, Thomas Deetz, complained that “pre-populating diagnoses into his visit encounter is possibly fraud. … Does CMS know about what you all are doing?” Deetz also did not respond to a request for comment.

Ormsby maintains that her multiple warnings about the practices were ignored or rebuffed. She said she received a poor performance review in early 2015, but by then she had already sought out private lawyers, a step that led to her whistleblower suit.

“I was finding too many errors, and they didn’t want to send the money back,” Ormsby said in the interview. Under rules for federal whistleblower lawsuits, Ormsby, 56, will receive 15 to 30 percent of the $90 million Sutter Health settlement.

‘Coding parties’

The practices at Sutter were not isolated, according to the government. Kaiser Permanente, a nonprofit health-care organization that treats patients in California, Colorado and elsewhere, including Virginia and Maryland, is accused in a separate Justice Department lawsuit of similar tactics that allegedly brought in about $1 billion in improper billings from 2009 to 2018. The case, which is pending, was consolidated from six whistleblower complaints against the company.

“As each year drew to a close, some employees referred to Kaiser’s rush to capture as many diagnoses as possible as the ‘dash for cash,’ ” the government said in its lawsuit. It alleges that at Kaiser Permanente, doctors were invited to “coding parties,” where physicians would be gathered in a room after hours and be expected to add diagnosis codes found in data-mining operations to current patient records.

Kaiser Permanente said in response to the government’s allegations that it was following the rules.

“We are confident that Kaiser Permanente is compliant with Medicare Advantage program requirements and we intend to strongly defend against the lawsuits alleging otherwise,” the company said in a statement sent to The Washington Post. “Our medical record documentation and risk adjustment diagnosis data submitted to the Centers for Medicare and Medicaid Services comply with applicable laws and Medicare Advantage program requirements. Our policies and practices represent well-reasoned and good-faith interpretations of sometimes vague and incomplete guidance from CMS.”

Internally, some doctors questioned the company’s practices, the lawsuit contends. Among the diagnoses Kaiser Permanente physicians were frequently asked to add to patient medical records was aortic atherosclerosis, according to the government’s lawsuit.

The condition, a hardening of the aorta wall, could often be observed incidentally in a chest X-ray or scan for some other ailment. Radiologists were instructed to record the presence of the condition if they detected any calcium in the aorta, “regardless of significance,” according to the government’s complaint.

Physicians would then be pressured via computerized queries to amend the patient records retroactively to include aortic atherosclerosis, which Kaiser had identified as having a “high rate of reimbursement” in the Medicare Advantage risk adjustment formula, the government alleged.

Some Kaiser Permanente doctors objected, saying the disorder was typically not serious in their elderly patients.

According to the government’s lawsuit, one physician, Matthew James Sena, observed in internal correspondence that “Aortic atherosclerosis is nearly ubiquitous in patients this age. It is not a clinically relevant diagnosis and doesn’t require treatment. Isolated [chest X-ray] interpretations are not grounds for clinical diagnosis in this case. … [It’s] clinically inconsequential in almost all cases.”

A coding administrator for Kaiser Permanente is quoted in the complaint as saying “[n]o one believes it is a real diagnosis,” and since “it is non-compliant to tell people to code for money, we need to really sort out a way to package this.”

Medicare Advantage programs are touted by industry as a way of ensuring that chronic conditions are carefully monitored through disease-management programs. But Kaiser Permanente’s increased diagnoses of aortic atherosclerosis threatened to create so many new patients with the condition that its disease management program for cardiovascular disease threatened to buckle.

Kaiser Permanente managers in 2011 came upon a solution, the government said: stop automatically enrolling aortic atherosclerosis patients in the cardiovascular disease management program.

Kaiser Permanente has been accused by the government in a civil whistleblower case of submitting false risk codes for Medicare Advantage patients to boost government payments. (iStock)

After the change, the lawsuit alleges, medical leaders continued to pressure doctors aggressively to code for the disorder, identifying it as worth an additional $40 million in annual billing opportunity at one physician practice.

“How do we rally the herd?” a physician executive director wrote to colleagues at Kaiser’s Northern California Medical Group, in an email quoted in the lawsuit. “Everybody join in the discussion. $40m is no chump change.”

‘Where’s follow-up care?’

Minnesota-based United Healthcare, the largest health-insurance company in the country, quotes a founding father on the homepage of HouseCalls, its program that dispatches clinicians to Medicare Advantage beneficiaries’ homes: “Benjamin Franklin said it best, ‘An ounce of prevention is worth a pound of cure.’ We agree.”

Under such initiatives, companies routinely send clinicians, often nurse practitioners, into patients’ homes to conduct “health risk assessments.” Companies say the assessments are intended to identify any risks to beneficiary health that their physicians may have overlooked or that have developed since their last doctor visit.

But government reports have questioned whether the practice is intended to improve or capture more lucrative diagnosis codes. The visits often result in new codes added to patient bills without any evidence of doctors’ having considered or treated the newfound diagnoses, the Office of Inspector General of the Department of Health and Human Services found in a report last year.

A Connecticut primary-care physician, Kenneth Dardick (whose spouse is the executive director of the Center for Medicare Advocacy, a nonprofit that advocates for patients), said he routinely receives copies of United Healthcare’s in-home risk assessments and never learns anything about his patients that he did not already know.

He does notice that new patient codes are added to the reports, documenting conditions he already knew about or were irrelevant, he said.

He shared a copy of one assessment, with identifying information of the patient removed, that was sent to him by HouseCalls in April. He was already treating the patient, a man in his 70s, for diabetes. But the health risk assessment, in a section called “new diagnosis,” had added a different code, diabetes with complications. The new diagnosis section also listed a personal history of a type of skin cancer. Dardick said a precancerous growth was removed from the patient’s skin nine years ago and is no longer being treated.

“My sense is they are doing that just to game the system,” Dardick said, citing the “new” diagnosis codes as “irrelevant.”

United Healthcare stood out among Medicare Advantage companies for its aggressive use of risk assessments without evidence new risk codes were related to ongoing medical care, according to the Office of Inspector General report last year. (OIG did not identify the company in its report, but it did confirm its identity after a records request from the Minneapolis Star-Tribune.)

United Healthcare has the largest share of Medicare Advantage patients in the country, with 7.2 million beneficiaries, or 27 percent of the total.

United Healthcare did not respond directly to the OIG report’s findings. In response to questions from The Post, spokesman Matt Wiggin emailed a brief statement. “Simply stated, compared to fee-for-service Medicare, Medicare Advantage costs less (for beneficiaries), is more equitable, has better quality, access, and outcomes with greater coverage and benefits and nearly 100% consumer satisfaction,” he said.

Jacqualine Reid, a government research analyst who led the review, said the findings about United Healthcare raised red flags. Of the $9.2 billion in risk adjustment payments in 2016 based on health risk assessments with no other records to support the diagnosis, United received $1.38 billion, Reid and her team found in their review.

The three top diagnoses generating those payments were peripheral vascular disease, major recurrent depressive disorder and Type 2 diabetes with peripheral angiopathy.

“These are serious medical conditions. If they are getting payments for in-home visits, but we do not see any other evidence of services being provided to them, it raises concern,” Reid said. “If they are appropriate, where’s the follow-up care that in most cases you would expect to see?”

FTC to investigate CVS Caremark, Humana, other pharmacy benefit managers

FTC to investigate CVS Caremark, Humana, other pharmacy benefit managers

https://www.foxbusiness.com/healthcare/ftc-investigation-cvs-caremark-humana-pharmacy-benefit-managers

A new investigation by the Federal Trade Commission will take aim at the prescription drug middlemen industry and pharmacy benefit managers.

Pharmacy benefit managers are hired to negotiate rebates and fees with drug manufacturers, create drug formularies and surrounding policies and reimburse pharmacies for patients’ prescriptions.

The FTC says that certain pharmacy benefit managers have “enormous influence” over which drugs are prescribed to patients, what pharmacies patients can use and how much patients ultimately pay at the pharmacy counter.

The agency will request records and other information from the six largest pharmacy benefit managers about their business practices. They include CVS Caremark, Cigna subsidiary Express Scripts Inc., UnitedHealth Group subsidiary OptumRx Inc., Humana Inc., Prime Therapeutics LLC and MedImpact Healthcare Systems Inc.

Ticker Security Last Change Change %
CVS CVS HEALTH CORP. 93.93 -1.99 -2.07%
CI CIGNA CORP. 260.66 -1.40 -0.53%
UNH UNITEDHEALTH GROUP INC. 493.52 -3.28 -0.66%
HUM HUMANA INC. 450.23 +0.44 +0.10%

The investigation will shed light on several practices that have been scrutinized in recent years, including: 

  • Fees and clawbacks charged to unaffiliated pharmacies
  • Methods to steer patients towards pharmacy benefit manager-owned pharmacies
  • Potentially unfair audits of independent pharmacies
  • Complicated and opaque methods to determine pharmacy reimbursement
  • The prevalence of prior authorizations and other administrative restrictions
  • The use of specialty drug lists and surrounding specialty drug policies
  • The impact of rebates and fees from drug manufacturers on formulary design and the costs of prescription drugs to payers and patients.

The FTC will issue compulsory orders under Section 6(b) of the FTC Act, which authorizes the agency to conduct studies without a specific law enforcement purpose. The companies will have 90 days from the date they receive the order to respond.

The Pharmaceutical Care Management Association (PCMA), a trade group representing pharmacy benefit managers, tells FOX Business that “drug manufacturer price-setting is the root cause of high drug costs.” 

“The most effective study of issues around drug costs for consumers would examine the entire supply chain,” PCMA president and CEO JC Scott said. “PBMs are holding drug companies accountable by negotiating the lowest possible cost on behalf of consumers, and by driving and delivering local competition that consumers are demanding.”

Representatives for CVS Caremark, Humana and Prime Therapeutics told FOX Business that they will cooperate with the FTC’s investigation. OptumRx deferred comment to the PCMA. The other companies did not return FOX Business’ request for comment. 

Chronic pain pts: SELF ADVOCATING to improve QOL & pain management

It would seem in hindsight, that the war on drugs was mostly built on racism, bigotry and lies.  It has been claimed that the Controlled Substance Act bill was signed into law by a President (“tricky dick nixon) that was known to be a racist/bigot and he wanted to throw blacks and “hippies” into jail. This law was design to deal with the “black drug market” that was created in 1914 by the Harrison Narcotic Act  https://en.wikipedia.org/wiki/Harrison_Narcotics_Tax_Act  This law created the Bureau of Narcotic and Dangerous Drugs  https://en.wikipedia.org/wiki/Bureau_of_Narcotics_and_Dangerous_Drugs  by combining Bureau of Narcotics (Dept of Treasury) & Bureau of Substance Abuse Control (under HHS). Moving dollars committed to deal with narcotic use/abuse/diversion  combined with abt 3 million budget and created the BNDD with a 43 million budget and 1500 agents.  In 1973, the BNDD transitioned into being the DEA.

Today the DEA has abt 10,000 employees – down to 2003 levels and 3.1 billion budget – up abt 50%-60% from 2003. That just tells part of the story, because many cities, counties, states.  Plus prisons (private & gov), our court system ( prosecuting attorneys, defense attorneys, judges & supporting staff ). Over the last 50+ yrs, the war on drugs has become a 100+ billion/yr INDUSTRIAL COMPLEX.

For those of you who believe that trying to talk to your member of Congress and/or getting the local media to cover the denial of care… here is the website for DEA Press Releases https://www.dea.gov/what-we-do/news/press-releases.  JUST TODAY (06/08/2022) the various DEA regional district and/or HQ put out SEVEN PRESS RELEASES to various media sources  – on how the DEA is winning the war on drugs..  A number of years ago – maybe during the Reagan Admin,  some entity within the Federal Gov was charged with making determination of how successful various federal agencies were in meeting their operational charge.  As I remember, the DEA got a GRADE OF ZERO !!!

I started this blog abt 10+yrs ago, just as the prescribing of opiates were peaking. I have seen many advocates come and go… I have seen some non-profits come and go..  I have seen some people who imply that they are part of a non-profit, when they are not..  While most all of these entities profess that they have the same goal, better pain management… but just like a ROAD MAP, there is numerous ways to get from point A to point B.  If everyone has a “different path” and won’t compromise/discuss different paths to come up with a compromise… then the odds of good results, probably decreases dramatically.

The first thing that the pt needs to get a answer to… is what intensity of pain does the practitioner expects the pt to live/exist in.  IMO, a pt’s intensity of pain can basically put into two levels .. =<5 is probably a tolerable level of pain and >5 is an intolerable level of pain and is most likely requiring the pt to live/exist in a torturous level of pain.

If the practitioner can only answer that whatever level of pain the pt has to exist/live in …depends on the MMG/day that the CDC’s guidelines states is the max allowable dose for all disease issues. If this is the limit to the practitioner’s treatment plan and the pt is willing to live/exist in the intensity of pain level that xx MME/day will provide, all advocacy efforts are finished.  If this is the answer to the pt’s treatment, or the pt can share this article with the practitioner  https://www.acsh.org/news/2022/03/01/true-story-morphine-milligram-equivalents-mme-16154 and ask the practitioner why he/she is limiting pain management therapy based on the MME system which has no science nor double blind clinical study behind it.

Here is a chart that demonstrates the possible complication of pt’s comorbidity from under/untreated pain …

If the practitioner, suggests/insists that you get  non-opiate, non-covered health services (PT, massages, aqua therapy, etc ) not covered by your insurance.  here is free software that has included in its package a spread sheet.  Just create a spread sheets for your monthly income and your monthly expenses… don’t  have to detail, just each month’s total expenses.  Ask the practitioner who he/she would suggest that you work the cost of such health services into your budget.  https://www.openoffice.org/download/index.html   If you don’t drive, how are you suppose to get to the medical appt ?

If  your BP increases dramatically (>180/100), when your pain meds are reduced/stopped, and even after given up to four different BP meds.. suggest that the following graphic be shared with the practitioner, to get confirmation that the practitioner understands the risk – you as their pt – are being put into… high blood pressure – per American Heart Association has always referred to as the “silent killer”

So the practitioner just tells you to take a NSAID (Aspirin, Motrin, etc) to manage your pain.  Just find a number of studies on warning the potential consequences to a pt using NSAIDS long term- kidney damage the most common.

So the practitioner just tells you to take Acetaminophen (Tylenol) to manage your pain.  Just find a number of studies on warnings the potential consequences to a pt using Acetaminophen long term – liver damage the most common

If your practitioner basically “blow your concerns off”, I would created a cover letter and I would take copies of all the information that you provided the practitioner and send them back to the office or dept that manages pt medical records and ask that they all be put into your medical records.  It might not do you, individually, much good, but your family will be able to sue the practitioner if/when you suffer a stroke, heart attack, eye/kidney/liver damage, premature death or commit suicide…  You have put your practitioner on notice that you made them aware that you were aware of the physical health consequences you may suffer, because of their plan of treatment of you.

Billion-Dollar Bounty for AARP: AARP collects $1 billion in these kinds of royalties

Billion-Dollar Bounty for AARP

The American Association of Retired Persons (AARP) agreed to an exclusive promotional deal in September with Oak Street Health, which operates 100 primary care clinics in a dozen states, according to Kaiser Health News.

The deal allows Oak Street Health to use AARP in its marketing for an undisclosed fee, according to the report.

This arrangement falls in line with a lucrative practice by the AARP, where the organization collects “royalties” in exchange for exclusive marketing deals with healthcare businesses eager to promote themselves to AARP’s membership.

In total, the AARP collects $1 billion in these kinds of royalties, according to its 2020 financial statement, KHN reported. About two thirds, or $752 million, of those royalties come from “health products and services,” according to the article. For comparison, AARP collected roughly $300 million in member dues in 2020.

There are questions about whether these partnerships are chosen because they benefit AARP’s members or because they are so profitable for the organization, according to the report. Marilyn Moon, who is a health policy analyst with ties to AARP since the 1980s, told KHN that it “certainly is a problem,” when the organization is profiting from these medicare-focused marketing partnerships while also lobbying on Medicare issues in Washington, D.C.

The partnership with Oak Street Health highlighted those concerns when the company came under investigation by the U.S. Department of Justice for its marketing tactics, KHN reported.

“It’s hard to know whether they’re advocating for their business interests or for the seniors that they are supposed to represent,” Joshua Gordon, director of health policy for the Committee for a Responsible Federal Budget, a nonpartisan group, told KHN.

when chronic pain advocates attack each other – does anyone really win ?

Abt 20% of our population get a monthly check from Medicare – forecast when funds will be unable to pay full benefits

Go-broke dates pushed back for Social Security, Medicare

https://www.foxbusiness.com/politics/go-broke-dates-pushed-back-social-security-medicare

The time frame for Social Security and Medicare to go-broke has been pushed back, helped by a stronger-than-expected economic recovery from the coronavirus pandemic.The annual Social Security and Medicare trustees report says the Social Security trust fund will be unable to pay full benefits beginning in 2035, instead of last year’s estimate of 2034. 

The projected depletion date for Medicare’s trust fund for inpatient hospital care moved back two years to 2028 from last year’s forecast of 2026.

The annual Social Security and Medicare trustees report says Social Security’s trust fund will be unable to pay full benefits in 2035.

According to the report, “Economic recovery from the 2020 recession has been stronger and faster than assumed in last year’s reports, with positive effects on the projected actuarial status of the trust funds in these reports.”

Forecasters said in the report that the ongoing COVID-19 pandemic will have no net effect on their long-range projections. 

The assumptions for the latest report were made in February, which was before cases began climbing again and inflation rose even higher.

President Biden said in a statement that the report “shows that the strong economic recovery driven by my economic and vaccination plans has strengthened programs that millions of Americans rely on and has put our nation in a better fiscal position.”

Social Security pays benefits to more than 65 million Americans, mainly retirees as well as disabled people and survivors of deceased workers. Medicare covers roughly 64 million older and disabled people.

A main source of financing for the programs is payroll taxes on earnings paid by employees and employers. About 183 million people paid those taxes in 2021.

Social Security retirees got a 5.9% boost in benefits this year, the biggest cost-of-living adjustment, also known as COLA, in 39 years.

What some hospital healthcare employees are saying about GUN VIOLENCE

What some hospital healthcare employees are saying about GUN VIOLENCE

https://www.beckershospitalreview.com/hospital-management-administration/michael-dowling-every-single-us-hospital-leader-should-be-screaming-about-what-an-abomination-this-is.html

Americans and global leaders have responded to the May 24 shooting at a Texas elementary school with heartbreak, anger and calls for change to better fight gun violence. But if you’re paying attention, the calls out of healthcare — from trauma surgeons, pediatricians, nurses, leaders and more — carry a distinct type of exasperation and sorrow. 

“I’m in one of my hospitals now, sitting with some staff talking about it — it’s just so frustrating,” Michael Dowling, president and CEO of New Hyde Park, N.Y.-based Northwell Health, told me over the phone early Wednesday morning. “This does not represent what the United States stands for — that we allow people who should never be allowed to carry a gun to do so and walk into a school and kill fourth graders.”

The attack by a lone 18-year-old gunman at Robb Elementary School in the small town of Uvalde, Texas, has left at least 19 students and two adults dead. Students in the school, grades 2 through 4, were two days away from summer vacation. 

Unlike many other known threats to our health, seeing the medical community condemn mass shootings still seems to leave some Americans doing a double take. It’s increasingly difficult to see what has them confused. 

In 2016, the American Medical Association declared gun violence a public health crisis after a lone gunman killed 49 people and wounded 53 more in a mass shooting in a gay nightclub in Orlando, Fla. Even after the declaration, healthcare professionals and leaders continued to defy insistence from gun rights advocates that gun violence was not within their specialty or expertise. Or as the National Rifle Association put it in simpler terms in 2018: “Someone should tell self-important anti-gun doctors to stay in their lane.” The #ThisIsOurLane movement started then. The attempt to silence medical professionals ironically made their calls for action louder.

As healthcare professionals responded to the ongoing public health emergency of COVID-19, the arms race grew and gun buying intensified — “a surge in purchasing unlike anything we’ve ever seen,” as one gun researcher at the University of California, Davis, put it. People who already owned guns bought more, and people who had never owned a gun bought them too. In 2020, firearm-related injuries were the No. 1 cause of death of children and teens, according to the CDC

Every day, 321 people are shot in the United States, and more than 40,000 Americans die from gun violence each year. Yet some healthcare executives still fear that taking the position that gun violence is a public health crisis will throw them into political turmoil given how toxic politics are in this country. It’s one position for the AMA and its 250,000-plus members to take, but another for an individual leader who may be the face of an organization in their community. There are risks of offending board members, donors, elected officials and other constituents ⁠— including patients. But here’s the thing: There will always be a reason to delay, to soften language, to wonder if this mass shooting is the one to react to.

Mr. Dowling urges his colleagues to step it up, noting how hospital and health system leaders can be ambassadors for gun safety in their communities, given the influence they wield as the largest employers in many communities.

“This is about protecting people’s health. This is about protecting kids’ lives. Have some courage. Stand up and do something,” he said. “Put the interest of the community in the center of what you think about each and every day. Our job is to save lives and prevent people from illness and death. Gun violence is not an issue on the outside — it’s a central public health issue for us. Every single hospital leader in the United States should be standing up and screaming about what an abomination this is.

“If you were hesitant about getting involved the day before May 24, May 24 should have changed your perspective. It’s time.”

Northwell established The Gun Violence Prevention Learning Collaborative for Health Systems and Hospitals, a grassroots initiative that gives healthcare professionals the space to have open dialogue about the impact of gun violence, share best practices and collectively take action. Learn more here

The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards

The GoodRx-Kroger Blowup: Spread Pricing, Pharmacy Margins, and the Future of Discount Cards

https://www.drugchannels.net/2022/05/the-goodrx-kroger-blowup-spread-pricing.html

A few weeks ago, GoodRx surprised investors with the unpleasant news that a major grocery chain had stopped accepting its discount card for an unspecified number of prescriptions. As I explain below, the unnamed chain appears to be Kroger—the sixth-largest U.S. pharmacy. What’s more, GoodRx disclosed that Kroger accounts for an unexpected one-quarter of its prescription business.

The GoodRx situation highlights crucial issues about the complex web of relationships and conflicts that support today’s discount card model. Below, I break down the economics of the discount card business to help frame the outlook for discount cards.

As I explain, discount cards are really just another form of spread pricing. As the market for patient-paid prescriptions has expanded, disputes about the appropriate split of these spreads will pressure pharmacy-PBM relationships and drive change in the discount card business model.

A well-known African proverb states: “When elephants fight, it’s the grass that suffers.” Will investors continue to support GoodRx—or move on to greener pastures? Read on and see what you think.

READ ME

Here are the relevant materials from GoodRx’s 2022:Q1 earnings announcement:

As always, I encourage you to review the original source material for yourself.

You may find it useful to review my previous articles about GoodRx and its business model:

I place GoodRx within the broader context of patient-paid prescriptions in Section 4.3. of DCI’s 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

TUSK TO TUSK

GoodRx described the unexpected financial surprise in its letter to shareholders:

“In addition, we recognized that a grocery chain had taken actions late in the first quarter of 2022 that impacted acceptance of discounted pricing for a subset of drugs from PBMs, who are our customers, and whose pricing we promote on our platform.”

On its earnings call, GoodRx disclosed that the chain accounted for less than 5% of the pharmacies in its retail network, but “almost one-quarter of its prescription transaction revenue.” That equates to about $38 million in GoodRx’s first quarter revenues, or about $150 million annually. The company projected that the financial impact would be roughly $30 million in the second quarter, but wouldn’t forecast beyond that point.

This was a startling disclosure. Like many other people, I was not aware that GoodRx had become so dependent on a single chain. Since the announcement, the company’s already depressed stock price has remained below $9. In early 2021, its stock price peaked at nearly $57. Ouch.

According to Wall Street analysts, the grocery chain that no longer accepts the GoodRx discount card for some or all prescriptions is Kroger. Multiple consumer posts on Twitter have confirmed this awkward reality. (For example, see here and here.)

We estimate that Kroger accounts for only 3% of total U.S prescription revenues. This suggests that GoodRx was dramatically over-indexed to a single chain.

As you can read in the earnings call transcript, GoodRx management tried valiantly to spin this situation. They correctly noted that the dispute is not between GoodRx and Kroger, but instead between Kroger and at least one of the PBMs that manages GoodRx’s retail discounts.

That’s why the GoodRx team made an analogy to the Walgreens/Express Scripts dispute from 2012. (They didn’t explicitly mention these two companies, but it’s clear from the context.) Travel back 10 years via the Drug Channels wayback machine for a refresher: Walgreens is Losing Its Battle with Express Scripts and Walgreen Cuts a Deal with Express Scripts.

I found GoodRx’s commentary to be confusing and hard to decipher. Here’s my take on what’s really going on.

DISCOUNT CARDS = SPREAD PRICING

Spread pricing is one way that third-party payers can compensate a PBM for plan administration and other services. With spread pricing, a payer compensates a PBM by permitting the PBM to retain differences, or spreads, between (a) the amount a PBM charges the payer, and (b) the amount the PBM pays the pharmacy that’s dispensing the prescription to a patient. We estimate that spread pricing has become much less important to large PBMs’ overall profitability. (See Section 11.2.3. of our 2022 pharmacy/PBM report.)

However, many people don’t appreciate that spread pricing is the primary way that PBMs profit from discount cards. Consequently, the Kroger/PBM dispute is really a fight over how this spread gets split.

The chart below illustrates the flow of products and money when a patient uses a discount card to pay the full cost of their generic drug prescription, without using third-party insurance. Since generic drug manufacturers don’t pay rebates to PBMs or payers, those flows have been eliminated from the chart.

[Click to Enlarge]

There are some notable differences from the conventional scenario illustrated in our well-known follow-the-dollar chart:

  • When using a discount card, the patient is the payer. There is no third-party payment for the prescription. The patient’s out-of-pocket payment comprises the pharmacy’s entire payment for the prescription. (More on this issue below.) In the chart above, the contractual and financial flows between PBMs and third-party payers have been removed.
  • The PBM collects a per-prescription fee from the pharmacy whenever a patient uses a discount card program. The pharmacy’s net reimbursement equals the patient’s prescription payment minus the discount card fee. Thus, this fee reflects a spread over the net reimbursement that the pharmacy earns. Like many other payers, patients generally don’t know that a PBM collects this fee.
  • The PBM doesn’t keep the entire discount card spread. The PBM shares a portion of this fee with the discount card vendor that directed the patient to the pharmacy. The PBM will pay the discount card vendor a percentage of its fee or a fixed per-prescription amount. Regardless of the form, GoodRx reports that it earns about 15% of the patient’s total retail prescription cost. See my commentary in this post from last August.

Assuming that PBMs don’t lose money on discount card prescriptions, then total discount card spreads are (on average) greater than 15% of the total retail consumer cost.

Let’s assume that GoodRx keeps 75% of discount card spread, while PBMs keep the remaining 25%. Here are some rough estimates of the GoodRx/PBM/Kroger prescription economics:

  • Total prescription revenue from consumers using GoodRx at Kroger pharmacies = $1 billion (= $150 million ÷ 15%)
  • GoodRx transaction revenue from Kroger = $150 million
  • PBM transaction revenue from GoodRx at Kroger = $50 million (assuming 25% of total discount card spread)
  • Net Kroger prescription revenues = $800 million (= $1 billion minus $200 million discount card spread)

Wow. Good money, if you can get away with it.

TRAMPLED UNDER FOOT?

The figures above are becoming crucial in understanding the forces driving the future of discount cards. Here are three trends to watch:

1) Patient-paid prescriptions are growing.

Prescription costs are increasingly shifted to patients through deductibles and coinsurance. Consequently, a growing share of prescriptions have no third-party contribution, because patients pay the full cost out of pocket.

What’s more, generic prescription pricing is so broken that more than 70% of the consumers who used GoodRx already had commercial or Medicare insurance. GoodRx has even estimated that more than half of prescriptions filled using its discount card were cheaper than the average commercial insurance copays for the 100 most purchased medications.

We estimate that patient-paid prescription accounted for about 9% of unadjusted prescriptions in 2021. Discount cards were more than half of this patient-paid prescription activity.

[Click to Enlarge]

Patient-paid prescriptions that use a discount card are not considered cash-pay, because the claims are adjudicated by a PBM. Thus, they lead to a consumerization of retail prescriptions—but not necessarily of the pharmacy and PBM industries.

2) Pharmacies will push back against shrinking discount card margins.

When a patient uses a discount card, the pharmacy must pay a fee for dispensing to a patient who may have been willing to pay the same prescription price directly to the pharmacy anyway. However, our wacky drug channel effectively prevents pharmacies from offering low cash prices that match the discount cards.

PBMs have been trying to expand these spreads, in part because discount card vendors are demanding ever-higher payment rates. Consequently, pharmacy margins for discount card prescriptions are being squeezed. This adds one more profit pressure to the long list of negative headwinds facing retail pharmacy.

Pharmacies will have a tough time recapturing these margins. Most areas of the U.S. have an oversupply of retail pharmacy locations.

3) PBMs will react to the danger from discount cards.

I have long postulated that discount cards could be the true disrupter that upends PBMs’ pharmacy benefit economics, plan sponsors’ decisions, and the entire generic market. Generic drugs account for nearly 90% of a PBM’s claims processing activity. Discount cards are incentivizing people to bypass their own insurance plans and access the network rates of another PBM—or even their own plan’s PBM disguised as a discount card.

PBMs have profited from discount cards’ rapid growth. I think they now recognize the dangers of this growth for the value of their benefit management services. Keep an eye on the following strategies:

  • PBMs are trying to increase discount cards spreads and/or retain a greater a portion of these spreads. So far, discount card vendors have been able to sustain their margins by working with smaller and hungrier PBMs that want to build their volume. For instance, GoodRx’s share of revenue from its three largest PBMs has been dropping, from 61% in 2018 to 34% in 2021. This suggests that the company is going deeper into the market to maintain competition.
  • PBMs are trying to insert some sort of “discount card” pricing into commercial benefit plans. Both Express Scripts and Prime Therapeutics have announced such programs. As I argued in a previous article, PBMs can hide behind discount cards to undermine the network rates offered to their own clients. I still have trouble understanding the circumstances in which a member’s out-of-pocket cost under a PBM-managed benefit plan would be higher than their cost using a discount card program operated by the same PBM.

In my recent video webinar PBM Industry Update: Trends, Controversies, and Outlook, I explained how patient-paid prescriptions could disrupt the PBM business.

Let’s see if GoodRx will be savvy enough to avoid becoming trampled grass.

Just saying…sharing

 

 

This Round/Brown/Smelly stuff has got to STOP!!!

PT called the clinic repeatedly complaining of pain and specifically targeted the doctor who performed the surgery

I heard it through the GRAPEVINE

A video diatribe attacking yours truly over something that I SHARED ?

A doctor’s murder over an opioid prescription leaves an Indiana city with no easy answers

It is unfortunate that a certain federal bureaucracy has allowed those with valid medical needs (chronic pain & mental health) to be divided and basically at odds over how each group is treated or MISTREATED and many healthcare providers are denying care to pts that would have probably got care while the Federal Law Decade of Pain Law (2000-2009) was active and on the books.   It is also pathetic that certain non profit groups have achieved some high visibility & credibility  because they have aligned themselves with the DEA’s agenda…  there is so many, I will not attempt to list them…. they know who they are and many within the chronic pain community know who they are.

So we basically have 4 different groups at odds  chronic pain pts, mental health/addiction pts, heatlhcare providers, and all those bureaucrats and non profits fighting the war on drugs/pts. It would seem like the last group or the suppressors and the first three are the victims.

The shooting of the two docs and office staff and pt recently WAS NOT A FIRST..  but the first that I am aware of was back in 2017 in Indiana, see link above.

The first video is from a pain doc calling a person out, who puts themself out as a “chronic pain advocate”…  I was recently told that this “chronic pain advocate” charges any pt who want them to advocate for them person to person … the upfront cost is $350 setup & $200/hr….  I don’t know if that is plus travel expense, room & board and related expenses or if “in person advocating” is a “virtual advocating”

The chronic pain community seems pretty “roused up” over what this “chronic pain advocate” posted on Tic Tok about the 4 murders and 1 suicide.

Will this incident cause the victims to come together and put up resistance to those that are suppressing hundred of millions of people with legit medical needs and the healthcare providers who would prefer to treat those people with valid medical necessities.

The chronic pain community needs to realize who is really behind and supporting them and who is attempting to monetize the chronic pain community in various ways.

I would not put any money on the various groups would come together, but THIS CRAP HAS GOT TO STOP.

FULL DISCLOSURE: I am the UNPAID consultant Pharmacist for the American Pain & Disability Foundation and I support what they are doing and what they have accomplished using only voluntary donations to the foundations.  Personally, I have never accepted the first dollar from a chronic pain pt for providing them advice on their particular issue/problem, and if anyone says otherwise…. IS A LIAR !!!